Accesso Biotech Corporation

Overview

New point of care (POC) CD4 tests for HIV/AIDS in low and middle income countries: easy to use, low cost with improved performance. For global health in LMIC regions.

Classification

This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices.

1. Manufacturing32
2. Chemical Manufacturing325
3. Pharmaceutical and Medicine Manufacturing32541
4. In-Vitro Diagnostic Substance Manufacturing325413

Capabilities